Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4510 results

Sort By:

PH Sensitive MRI Based Resections of Glioblastoma

Study ID: NCT06176066
Start Date: 2025-07-01
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

CEST PH MRI based resection of glioblastoma

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list

Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment

Study ID: NCT05901766
Start Date: 2025-05-01
End Date: 2026-01-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

600

Intervention / Treatment

UNIMAP Multiple Micronutrient Supplement

Sponsor

Brown University

Source: clinicaltrials.gov

Share:
Add to list

Effects of Milk Powder Intervention on Blood Glucose Control and Fluctuation in Middle-aged and Elderly People with Pre-diabetes

Study ID: NCT06863766
Start Date: 2025-04-01
End Date: 2026-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

fortified formula milk powder group

regular milk powder group

Sponsor

Hui Z Tiger

Source: clinicaltrials.gov

Share:
Add to list

Study Evaluating the Efficacy and Tolerance of a Zanubrutinib and BGB-11417 Combination in Patients Previously Treated for Waldenström Macroglobulinemia

Study ID: NCT06547866
Start Date: 2025-06-01
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

102

Intervention / Treatment

zanubrutinib + BGB-11417

Sponsor

French Innovative Leukemia Organisation

Source: clinicaltrials.gov

Share:
Add to list

A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

Study ID: NCT06891066
Start Date: 2025-04-21
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

ISL

Head

BIC/FTC/TAF

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Closing the GAPS: Guideline Adherence, Prevention and Surveillance in Hereditary Cancer

Study ID: NCT06654466
Start Date: 2025-09-01
End Date: 2027-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Nest, an electronic medical record (EMR)-integrated software platform to deliver longitudinal, genetics-based care at scale.

Sponsor

Nest Genomics

Source: clinicaltrials.gov

Share:
Add to list

Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas

Study ID: NCT06455189
Start Date: 2025-06
End Date: 2029-12-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

114

Intervention / Treatment

Control Group - Standard of care neurosurgical resection

MRF/MRI infiltration guidance for extended resection

Sponsor

Case Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

The Power Down Pilot Study: a Novel Bedtime Manipulation Protocol

Study ID: NCT06386029
Start Date: 2025-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Power Down bedtime manipulation

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

NOTRE: Optimizing Long-Acting Pre-Exposure Prophylaxis and Medications for Opioid Use Disorder Interventions in Carceral Settings

Study ID: NCT06854029
Start Date: 2025-11
End Date: 2030-06
Study Type

Interventional

Study Phase

Phase4

No. of Participants

300

Intervention / Treatment

Cabotegravir Injection

Cabotegravir Pill

Buprenorphine injection

Buprenorphine Pill

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

Study ID: NCT06232044
Start Date: 2025-05-01
End Date: 2030-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

88

Intervention / Treatment

Iberdomide

Mafodotin Belantamab

Dexamethasone

Echocardiography

Computed Tomography

Magnetic Resonance Imaging

Positron Emission Tomography

Bone Marrow Biopsy

Bone Marrow Aspiration

Biospecimen Collection

Sponsor

Alliance for Clinical Trials in Oncology

Source: clinicaltrials.gov

Share:
Add to list